Solventum CorporationSOLVNYSE
Loading
R&D Expenses Over TimeStable
Percentile Rank20
3Y CAGR-1.2%
5Y CAGR+0.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-1.2%/yr
Annual compound
5Y CAGR
+0.6%/yr
Consistent
Percentile
P20
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $739.00M | -4.6% |
| 2024 | $775.00M | +2.2% |
| 2023 | $758.00M | -1.2% |
| 2022 | $767.00M | +0.1% |
| 2021 | $766.00M | +6.5% |
| 2020 | $719.00M | - |